Insider Trading History of Frazier Kenneth C

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Frazier Kenneth C since 2015. This trader's CIK number is 1181175. At the time of last reporting, Frazier Kenneth C was the Officer of Eikon Therapeutics, Inc.. (stock ticker symbol EIKN). Also see all insider trading activities at Eikon Therapeutics, Inc..

Note that in the past FRAZIER KENNETH C also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Eikon Therapeutics, Inc. (EIKN) by Frazier Kenneth C

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2026 EIKN 111,111 $1,999,998 0 $0 0 $0

Yearly summary of insider trading at Merck & Co., Inc. (MRK) by Frazier Kenneth C

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 MRK 0 $0 470,000 $46,457,855 470,000 $0
2021 MRK 0 $0 663,881 $54,918,227 663,881 $0
2020 MRK 0 $0 280,000 $22,793,680 0 $0
2019 MRK 0 $0 694,698 $55,607,936 694,698 $27,294,680
2018 MRK 0 $0 787,792 $54,606,786 787,792 $28,101,435
2016 MRK 0 $0 592,000 $36,869,345 592,000 $19,623,199
2015 MRK 0 $0 32,670 $1,875,981 38,622 $1,311,307


Insider trading activities at 2 companies by Frazier Kenneth C:

1. Eikon Therapeutics, Inc. (EIKN)

2. Merck & Co., Inc. (MRK)

Table 1. Insider trading of Eikon Therapeutics, Inc. (EIKN) by Frazier Kenneth C

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2026-02-04 EIKN Buy 111,111 18.00 1,999,998

Table 2. Insider trading of Merck & Co., Inc. (MRK) by Frazier Kenneth C

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-11-03 MRK Sale 235,000 98.89 23,238,210
2022-11-04 MRK Sale 235,000 98.81 23,219,645
2022-11-03 MRK Option Ex 235,000 .00 0
2022-11-04 MRK Option Ex 235,000 .00 0
2021-11-09 MRK Option Ex 663,881 .00 0
2021-11-09 MRK Sale 663,881 82.72 54,918,227
2020-11-09 MRK Sale 280,000 81.41 22,793,680
2019-03-20 MRK Option Ex 192,736 39.29 7,572,597
2019-03-20 MRK Sale 192,736 82.05 15,813,410
2019-03-13 MRK Sale 18,725 82.00 1,535,450
2019-03-13 MRK Option Ex 18,725 39.29 735,705
2019-03-05 MRK Sale 6,961 82.00 570,808
2019-03-04 MRK Sale 13,144 82.00 1,077,873
2019-03-05 MRK Option Ex 6,961 39.29 273,497
2019-03-04 MRK Option Ex 13,144 39.29 516,427
2019-02-22 MRK Sale 53,961 80.02 4,318,067
2019-02-22 MRK Option Ex 53,961 39.29 2,120,127
2019-02-21 MRK Sale 41,992 80.00 3,359,443
2019-02-21 MRK Option Ex 41,992 39.29 1,649,865
2019-02-15 MRK Sale 92,913 80.03 7,436,199
2019-02-19 MRK Option Ex 42,700 39.29 1,677,683
2019-02-19 MRK Sale 42,700 80.02 3,416,939
2019-02-15 MRK Option Ex 92,913 39.29 3,650,551
2019-02-05 MRK Option Ex 231,566 39.29 9,098,228
2019-02-05 MRK Sale 231,566 78.08 18,079,747
2018-10-02 MRK Sale 279,850 72.07 20,168,229
2018-10-02 MRK Option Ex 279,850 36.56 10,231,316
2018-09-18 MRK Option Ex 279,851 36.56 10,231,352
2018-09-18 MRK Sale 279,851 70.08 19,611,958
2018-07-31 MRK Sale 228,091 65.00 14,826,599
2018-07-31 MRK Option Ex 228,091 33.49 7,638,767
2016-11-10 MRK Sale 133,920 65.03 8,709,353
2016-11-09 MRK Sale 6,080 65.00 395,200
2016-11-10 MRK Option Ex 133,920 23.45 3,140,424
2016-11-09 MRK Option Ex 6,080 23.45 142,576
2016-08-05 MRK Option Ex 392,000 33.88 13,279,000
2016-08-05 MRK Sale 392,000 61.95 24,284,792
2016-07-05 MRK Option Ex 27,621 51.02 1,409,223
2016-07-01 MRK Sale 32,379 58.00 1,877,982
2016-07-01 MRK Option Ex 32,379 51.02 1,651,976
2016-07-05 MRK Sale 27,621 58.00 1,602,018
2015-10-29 MRK Option Ex 18,666 35.09 654,989
2015-10-29 MRK Sale 18,666 54.69 1,020,750
2015-02-18 MRK Option Ex 7,082 31.84 225,490
2015-02-18 MRK Sale 5,164 58.67 302,961
2015-01-09 MRK Sale 8,840 62.47 552,270
2015-01-09 MRK Option Ex 12,874 33.47 430,828

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Frazier Kenneth C (Officer of Eikon Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.